(±)-(1-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetic acid | 56846-85-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: (±)-(1-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetic acid
• 英文别名: 1-Methyltetralyl-1-acetic acid；2-(1-methyl-3,4-dihydro-2H-naphthalen-1-yl)acetic acid
• CAS: 56846-85-6
• 化学式: C₁₃H₁₆O₂
• 分子量: 204.269
• InChiKey: JPXIKFFDOJPPCM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (±)-(1-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetic acid 在 双(三甲基硅烷基)氨基钾 、 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 生成 1,1,1-trifluoro-3-(1-methyl-1,2,3,4-tetrahydro-1-naphthalenyl)-2-propanone
  参考文献：
  名称：

  Non-steroidal glucocorticoid agonists—The discovery of aryl pyrazoles as A-ring mimetics

  摘要：

  Starting from an established series of non-steroidal glucocorticoid receptor (GR) agonists, a large array was designed where a metabolically labile benzoxazinone moiety was replaced. Initial hits bound to GR but lacked agonist activity. Following two further iterations, potent GR agonists were discovered with 20D1E1 having NF kappa B agonism pIC(50) 8-8 (103%). Other analogues such as 23D1E1 display a dissociated profile (NF kappa B pIC(50) 8.1 (103%), MMTV pEC(50) 7.02 (36%)). The tetrahydronaphthalene moiety can also be replaced with substituted aryls such as 24E1 and 25E1. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.06.066
• 作为产物：
  描述：

  4-Methyl-4-carboxymethyl-tetralon-(1) 在 氢氧化钾 、 一水合肼 、 二乙二醇 作用下， 生成 (±)-(1-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetic acid
  参考文献：
  名称：

  Palladium- vs. peroxide-promoted decarbonylation of neophyl-like aldehydes

  摘要：

  DOI：

  10.1021/jo00913a004

文献信息

• [EN] HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS HÉTÉROCYCLYLE ET LEUR UTILISATION COMME MODULATEURS DE RÉCEPTEURS DE LA PROSTAGLANDINE D2
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2013093842A1

  公开（公告）日：2013-06-27

  The present invention relates to phenyl-substituted heterocyclyl derivatives of the formula (I) wherein Z, n, m, R1, R2, R3, R4, R5, R6, R7 and R8 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin D2 receptor modulators, in the treatment of various prostaglandin-mediated diseases and disorders, to pharmaceutical compositions containing these compounds and to processes for their preparation.

  本发明涉及式(I)的苯基取代杂环基衍生物，其中Z、n、m、R1、R2、R3、R4、R5、R6、R7和R8如描述中所述，并且它们作为前列腺素受体调节剂的用途，尤其作为前列腺素D2受体调节剂，在治疗各种前列腺素介导的疾病和紊乱中的用途，以及含有这些化合物的药物组合物和其制备方法。
• A new synthetic approach to benzomorphans
  作者：C.W. Bird、A.L. Brown

  DOI：10.1016/s0040-4020(01)83490-6

  日期：1985.1

  A new approach to the synthesis of benzomorphan derivatives is exemplified by the obtention of 3,6-dimethyl-benzomorphan from the readily available 1-methyl-2,3-benzobicyclo-[3,2,l]octane-4,6-dione.

  从容易获得的1-甲基-2,3-苯并双环-[3,2,1]辛烷-4​​,6-二酮中获得3,6-二甲基-苯并吗啡酸是合成苯并吗啡衍生物的一种新方法。 。
• Heterocyclyl Derivatives and their use as Prostaglandin D2 Receptor Modulators
  申请人：Actelion Pharmaceuticals Ltd.

  公开号：US20150252036A1

  公开（公告）日：2015-09-10

  The present invention relates to phenyl-substituted heterocyclyl derivatives of the formula (I), wherein Z, n, m, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin D 2 receptor modulators, in the treatment of various prostaglandin-mediated diseases and disorders, to pharmaceutical compositions containing these compounds and to processes for their preparation.

  本发明涉及公式（I）的苯基取代杂环基衍生物，其中Z，n，m，R1，R2，R3，R4，R5，R6，R7和R8如描述中所述，并且它们作为前列腺素受体调节剂的用途，特别是作为前列腺素D2受体调节剂，在治疗各种前列腺素介导的疾病和疾患中使用，以及包含这些化合物的制药组合物和它们的制备过程。
• Carbo-Carboxylation of Alkenes via Intramolecular Heck Carbonylation Utilizing CO₂ and Hydrosilane
  作者：Meng-Meng Wang、Sheng-Mei Lu、Can Li

  DOI：10.1021/acscatal.2c03478

  日期：2022.9.2

  carbo-carboxylation of alkenes has been achieved using an easily accessible Pd/monophosphine ligand combination as the catalyst. This protocol provides competent access to construct a series of 2,3-dihydrobenzofurans, chromans, isochroman, indanes and tetralins bearing a β-acid moiety in moderate to excellent yield. Additionally, the example of domino carbo-carbonylation reactions has been demonstrated

  从由 CO 2和 PMHS（聚甲基氢硅氧烷）原位形成的多种烯烃束缚芳基卤化物和甲酸甲硅烷酯开始，使用易于获得的 Pd/单膦配体组合作为催化剂实现烯烃的碳羧化。该协议提供了构建一系列 2,3-二氢苯并呋喃、色满、异色满、茚满和四氢萘的能力，这些产品具有中等至极好的产量。此外，多米诺碳羰基化反应的例子已被证明使用二烯束缚芳基碘化物作为起始材料，以良好的收率形成含氧双环产物。推测烯烃的碳羧化反应通过碳甲硅烷氧基羰基化途径进行。
• WILT J. W.; PAWLIKOWSKI JR. W. W., J. ORG. CHEM. <JOCE-AH>, 1975, 40, NO 25, 3641-3644
  作者：WILT J. W.、 PAWLIKOWSKI JR. W. W.

  DOI：——

  日期：——